GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTK Healthcare Ltd (BOM:507747) » Definitions » 3-Year EBITDA Growth Rate

TTK Healthcare (BOM:507747) 3-Year EBITDA Growth Rate : 29.30% (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is TTK Healthcare 3-Year EBITDA Growth Rate?

TTK Healthcare's EBITDA per Share for the three months ended in Dec. 2023 was ₹15.04.

During the past 12 months, TTK Healthcare's average EBITDA Per Share Growth Rate was 74.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 29.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of TTK Healthcare was 252.60% per year. The lowest was -22.80% per year. And the median was 11.70% per year.


Competitive Comparison of TTK Healthcare's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, TTK Healthcare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTK Healthcare's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's 3-Year EBITDA Growth Rate falls into.



TTK Healthcare 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


TTK Healthcare  (BOM:507747) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


TTK Healthcare 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of TTK Healthcare's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


TTK Healthcare (BOM:507747) Business Description

Traded in Other Exchanges
Address
No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.

TTK Healthcare (BOM:507747) Headlines

No Headlines